Independent Portfolio Consultants’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.45M Buy
5,961
+4,320
+263% +$1.02M 0.6% 25
2017
Q1
$392K Buy
1,641
+79
+5% +$18.4K 0.14% 240
2016
Q4
$328K Sell
1,562
-644
-29% -$133K 0.11% 254
2016
Q3
$508K Buy
2,206
+80
+4% +$19.5K 0.16% 223
2016
Q2
$491K Sell
2,126
-1,071
-34% -$247K 0.15% 220
2016
Q1
$857K Sell
3,197
-105
-3% -$30.1K 0.24% 130
2015
Q4
$1.03M Sell
3,302
-2,900
-47% -$863K 0.31% 99
2015
Q3
$1.69M Buy
6,202
+10
+0.2% +$3.07K 0.37% 89
2015
Q2
$1.88M Sell
6,192
-1,576
-20% -$470K 0.38% 78
2015
Q1
$2.31M Sell
7,768
-429
-5% -$122K 0.47% 60
2014
Q4
$2.11M Buy
8,197
+5,453
+199% +$1.36M 0.42% 72
2014
Q3
$662K Buy
2,744
+659
+32% +$147K 0.18% 163
2014
Q2
$465K Buy
2,085
+240
+13% +$49.7K 0.13% 256
2014
Q1
$379K Buy
1,845
+115
+7% +$22.8K 0.12% 316
2013
Q4
$291K Buy
+1,730
New +$270K 0.1% 371

Other funds holding AGN

Independent Portfolio Consultants's AGN Position: Q2 2017 in Review

Independent Portfolio Consultants increased its Allergan plc (AGN) stake by 263% in Q2 2017, buying an estimated $1.02M and bringing the position to 5,961 shares worth $1.45M. The position accounts for 0.6% of the portfolio, ranked #25.

Independent Portfolio Consultants first reported a position in AGN in Q4 2013 and has held it in 15 quarters since. The position peaked at $2.31M in Q1 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Independent Portfolio Consultants held 5,961 shares of Allergan plc worth $1.45M as of Q2 2017.
  • Independent Portfolio Consultants bought 4,320 Allergan plc shares in Q2 2017, an estimated $1.02M.
  • Allergan plc made up 0.6% of Independent Portfolio Consultants's portfolio in Q2 2017, its #25 holding.
  • Independent Portfolio Consultants first reported a position in Allergan plc in Q4 2013 and has held it in 15 quarters since.
  • Independent Portfolio Consultants's Allergan plc position peaked at $2.31M in Q1 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.